Hosted on MSN20d
A next-gen Ozempic falls short in a drug trial — and Novo Nordisk stock plunges 20%The logo of Danish pharmaceutical company Novo Nordisk is pictured at their headquarters in Bagsvaerd outside of Copenhagen, Denmark on February 1, 2017. Novo Nordisk (NVO) released mixed clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback